Zota Health Care valuation

·UnclassifiedChart ›
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Price multiples — at each FY-end close
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
6.87×————
6.33×————
Enterprise multiples
6.36×————
−15,744.38×————
−40.77×————
Yield
−2.6%————
−2.0%————
Reference — adjusted share basis
₹1,241.10————
−₹32.57−₹21.35−₹16.28−₹4.14−₹1.67
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZOTA₹1,241.10

Zota Health Care LImited

· Unclassified
₹ CrorePeersMARINEBETATHEJOMcap ₹4,298 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/B————6.87
P/Sales————6.33
Enterprise Multiples
EV/Sales————6.36
EV/EBITDA————-15,744.38
EV/EBIT————-40.77
Yield
Earnings Yield %————-2.62
FCF Yield %————-1.96
Reference — adjusted share basis
Price (FY-end close, adj.)————1,241.10
EPS (adj.)-1.67-4.14-16.28-21.35-32.57
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.